Results 111 to 120 of about 25,921 (246)
Artificial intelligence (AI) is receiving increasing attention across the entire lifecycle of medicines, from early development to postauthorization use. While various AI tools have been developed in commercial and academic settings, the extent of their use in regulatory contexts within the European Union remains unknown.
Lucina‐May Nollen +3 more
wiley +1 more source
The promotion of data sharing in pharmacoepidemiology
This article addresses the role of pharmacoepidemiology in patient safety and the crucial role of data sharing in ensuring that such activities occur. Against the backdrop of proposed reforms of European data protection legislation, it considers whether ...
Sethi, Nayha
core +1 more source
ABSTRACT Aim Immunocompromised children (IC) were presumed to be at higher risk of SARS‐COV‐2 infection and severe COVID‐19, but population‐based evidence is limited. We assessed infection risk, COVID‐19 hospitalisation, and severe outcomes in IC compared with children with and without other high‐risk conditions.
Costanza Di Chiara +13 more
wiley +1 more source
ABSTRACT Background Zopiclone was recently identified as a frequent contributor to fatal drug‐intoxications in Sweden. However, characteristics of misuse and factors associated with prescribed use remain insufficiently described. Alprazolam has a more established misuse profile. Objective The aim of the study was to describe and compare characteristics
Lova Tralla +4 more
wiley +1 more source
Cost-Effectiveness of Itopride Hydrochloride for the Treatment of Functional Dyspepsia in Vietnam
Background/Objectives: Functional dyspepsia is associated with abdominal pain and nausea, which leads to reduced quality of life, loss of productivity, and economic loss for patients.
Hansoo Kim +5 more
doaj +1 more source
The Asian Pharmacoepidemiology Network (AsPEN) is a multi-national research network, which was formed to provide a mechanism to support the conduct of pharmacoepidemiological research and to facilitate the prompt identification and validation of emerging
Setoguchi, Soko +18 more
core
ABSTRACT Aims To investigate the association between use of GLP‐1 receptor agonists and incident Parkinson's disease. Material and Methods Cohort study using data from nationwide registers in Denmark, Norway and Sweden and an active‐comparator, new‐user design.
Arvid Engström +10 more
wiley +1 more source
Background/Objectives: Direct oral anticoagulants (DOACs), when compared to the Vitamin K antagonist (VKA) warfarin, exhibit greater safety and effectiveness.
Shu-Yu Yao +3 more
doaj +1 more source
Despite one-third of the world lacking access to essential medicines, a dearth of pharmaceutical policy research in developing countries has resulted in policy decisions based upon opinion and conventional wisdom rather than evidence.
Pharmacoepidemiology +2 more
core

